Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Parliamentary Panel Slams CDSCO for Slow Drug Approvals, Calls for Conditional Licensing in 45 Days

CDSCO, ICMR Release Draft IVD Protocols for Arboviral Diagnostics, Seek Feedback

Farhat Nasim6 Jan 2025 2:25 PM IST

New Delhi: The Central Drugs Standard Control Organisation (CDSCO) and the Indian Council of Medical Research (ICMR) have jointly released draft...

Parliamentary Panel Questions Rejection of NIMERs Proposal, Demands Explanation

Farhat Nasim6 Jan 2025 2:24 PM IST

New Delhi: A Parliamentary panel has expressed its concern over the Department of Expenditure's (DoE) decision to reject the Department of...

Drug alert: CDSCO flags 60 formulations as not of standard quality

CDSCO Moves Clinical Trial Site Addition, PI Change Applications to Online Platform

Farhat Nasim2 Jan 2025 2:08 PM IST

New Delhi: The Central Drugs Standard Control Organization (CDSCO), under the Directorate General of Health Services, has announced a streamlined...

Around 3000 Himachal Doctors Failed to Renew License to Practice

Breather for D.Pharm Graduates: PCI Grants One-Year Provisional Licenses Amid Exit Exam Delays

Farhat Nasim2 Jan 2025 12:59 PM IST

Nagpur: The Pharmacy Council of India (PCI) has come to the aid of Diploma in Pharmacy (D.Pharm) students from the 2022-2023 batch by permitting...

Batch of Telma AM earlier classified as NSQ now flagged as Spurious

CDSCO Flags PAN-40, AUGMENTIN Batches as Spurious in November 2024 Alert

Farhat Nasim1 Jan 2025 2:22 PM IST

New Delhi: The Central Drugs Standard Control Organization (CDSCO) has declared certain batches of Pantoprazole Gastro-Resistant Tablets I.P....

Govt Invites Pharma Firms to Submit Data for Ceiling Price Review

NPPA to Re-Examine Iohexol Injection Price Challenged by JB Chemicals

Farhat Nasim31 Dec 2024 6:47 PM IST

New Delhi: In a respite to Mumbai-based JB Chemicals and Pharmaceuticals, the Department of Pharmaceuticals (DoP) has directed the National...

Karnataka HC Orders FIR Against Two Doctors for Operating without Consent

Karnataka HC Stays Action Against Pharma Firms Producing Nutraceuticals in Drug Facilities

Farhat Nasim30 Dec 2024 5:43 PM IST

Bengaluru: In a significant move for the pharmaceutical sector, the Karnataka High Court has directed the government to abstain from taking...

Parliamentary Panel Slams NPPA for 50% Price Hike, Demands Answers

Farhat Nasim25 Dec 2024 5:02 PM IST

New Delhi: The Parliamentary Standing Committee on Chemicals and Fertilisers has slammed the National Pharmaceutical Pricing Authority (NPPA) for...

Court denies bail to Khyati Hospital Chairman

No Bail for Pharma Firm Owner Accused of Producing Spurious Drugs

Farhat Nasim24 Dec 2024 6:03 PM IST

The court noted that granting bail would encourage other drug manufacturers to produce and market spurious drugs for easy money.

Rs 1.91 Crore spent on Doctors Travel: Pharma Company faces UCPMP heat, soon action against 30 doctors

Farhat Nasim24 Dec 2024 12:43 PM IST

New Delhi: In a first of its kind case under the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, the Apex Committee for Pharma...

CDSCO Committee Calls for Stronger Action Against Fake Medicines, Stricter Quality Checks

Only 5.9% Spurious Drug Cases Resolved: Parliamentary Panel Slams Govt

Farhat Nasim23 Dec 2024 5:17 PM IST

New Delhi: Take stringent action in a time bound manner for exemplary punishments for spurious/adulterated drugs, the Parliamentary Standing...

Indian Pharma Market to Hit Rs 2.38 Lakh Crore by 2025: Pharmarack Report

Farhat Nasim22 Dec 2024 12:00 PM IST

New Delhi: The Indian Pharma Market (IPM) is set to grow by 8.2% in 2025, reaching Rs 2.38 lakh crore under a realistic scenario, according to...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok